latentbrief
Back to news
Launch4d ago

MIT and Boston Children's Team Up With AI to Revolutionize ALS Research

DeepMind Safety1 min brief

In brief

  • MIT's Ritu Raman and Boston Children's Hospital's Ryan Flynn are using Co-Scientist, an advanced AI tool, to bridge their expertise in tissue engineering and RNA mapping.
    • This collaboration is tackling Amyotrophic Lateral Sclerosis (ALS) by combining Raman's ability to model diseases with living tissues and Flynn's insights into RNA-driven cellular communication.
  • Co-Scientist streamlined a complex literature review, helping Raman identify promising research paths quickly.
  • However, decoding molecular interactions at the cell surface required Flynn's expertise.
  • Together, they integrated AI's suggestions into their work, focusing on RNA-based mechanisms for potential new therapies.
    • This partnership highlights how AI can accelerate scientific discovery by connecting diverse fields.
  • As Co-Scientist helps researchers explore innovative pathways, we'll likely see more breakthroughs in understanding and treating diseases like ALS.

Terms in this brief

Co-Scientist
An advanced AI tool designed to assist researchers by streamlining literature reviews and suggesting research paths. It helps connect diverse scientific fields to accelerate discovery, as demonstrated in ALS research where it collaborated with tissue engineering and RNA mapping experts.

Read full story at DeepMind Safety

More briefs